Document is current
Any future updates will be listed below
-
Authors
Ivančić, Dimitrije https://orcid.org/0000-0002-7936-0468
Agudelo, Alejandro https://orcid.org/0009-0008-5515-3975
Lindstrom-Vautrin, Jonathan
Jaraba-Wallace, Jessica
Gallo, Maria
Das, Ravi
Ragel, Alejandro
Herrero-Vicente, Jorge
Higueras, Irene
Billeci, Federico
Sanvicente-García, Marta https://orcid.org/0000-0002-4508-2834
Petazzi, Paolo
Ferruz, Noelia https://orcid.org/0000-0003-4172-8201
Sánchez-Mejías, Avencia
Güell, Marc https://orcid.org/0000-0003-4000-7912
-
Funding
Funding for this research was provided by:
EC | Horizon 2020 Framework Programme (825825)
Ministry of Economy and Competitiveness | Agencia Estatal de Investigación (PID2020-118597RB-I00)
- License Information
-
More Information
Article History
Received: 27 November 2024
Accepted: 19 August 2025
First Online: 2 October 2025
Competing interests
: A.A., J.L.-V., J.J.-W., M. Gallo, M.S.-G., R.D., M. Güell, A.S.-M., N.F. and D.I. are employed or have consulted for Integra Therapeutics. M. Güell and A.S.-M. are shareholders of Integra therapeutics. D.I., M. Güell, A.S.-M., A.A. and R.D. have filed a patent application (US Patent application no. 63/505485) related to this work.
